论文部分内容阅读
目的:探讨奥曲肽在肝硬化伴食管静脉曲张破裂出血患者中的临床应用效果。方法:选取106例肝硬化伴食管静脉曲张破裂出血患者为研究对象,应用随机数字表法将其分为观察组和对照组,对照组给予奥曲肽对其进行治疗,观察组患者给予垂体后叶素进行治疗,进行为期48h的临床观察,比较对照组和观察组临床治疗效果。结果:观察组有效率为83.02%,对照组有效率为64.15%,两组治疗有效率比较差异有统计学意义(P<0.05)。结论:奥曲肽治疗肝硬化伴食管胃底静脉曲张破裂出血临床疗效确切,不良反应少,值得推广应用。
Objective: To investigate the clinical effect of octreotide in patients with cirrhosis and esophageal variceal bleeding. Methods: A total of 106 patients with cirrhosis and esophageal variceal bleeding were enrolled in this study. They were divided into observation group and control group using random number table. The control group was treated with octreotide, and the observation group was given pituitrin For treatment, for a period of 48h clinical observation, compare the clinical efficacy of the control group and the observation group. Results: The effective rate was 83.02% in the observation group and 64.15% in the control group, the difference was statistically significant (P <0.05). Conclusion: Therapeutic effect of octreotide on patients with cirrhosis and esophagogastric variceal bleeding is accurate and has few adverse reactions. It is worth popularizing and applying.